Popular weight loss drugs linked to a surprising fingernail problem
ScienceDaily reports on a cross-sectional, multinational study presented at the EADV Congress 2026 comparing 575 GLP-1 users with 1,329 people with type 2 diabetes and/or obesity who never used the drugs. Self-reported nail detachment affected 39% of users versus 9% of nonusers, and hair loss and scalp redness were also more common. Researchers stress the findings reflect association, not causation. DUCRAY Laboratories supported the work.
Why it matters: Relevant to Maryland adults with obesity or type 2 diabetes using or considering GLP-1 medications, and to the clinicians who refer or monitor them.
A summary of another publisher's reporting, written with AI and checked automatically against the story. The reporting belongs to sciencedaily.com. October 12, 2026.
